M. Peter Marinkovich, MD

The associate professor of dermatology at Stanford University discussed how the May 2023 approval of B-VEC may shift the treatment field for RDEB.

The associate professor of dermatology at Stanford University discussed the potential impact of Vyjuvek’s approval in the derm field.

The associate professor of dermatology at Stanford University discussed his experiences investigating and helping to develop Vyjuvek, approved for treating DEB.